EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer

Joshua D Smith, Elizabeth Gensterblum-Miller, David W A Forner, Pratyusha Yalamanchi, Marisa R Buchakjian, Steven B Chinn, Andrew G Shuman, Keith A Casper, Kelly M Malloy, Chaz L Stucken, Scott A Mclean, Michelle L Mierzwa und 7 weitere

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Joshua D Smith und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, CD8-Positive T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Tumor Hypoxia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We assessed correlations between tumor carbonic anhydrase IX (CAIX) staining, as a marker of tumor hypoxia, and CD8 + T‐cell infiltration in a cohort of patients with advanced laryngeal squamous cell carcinoma undergoing a bioselection approach for definitive treatment. Study Design Retrospective cohort study.

Setting

Tertiary care hospital.

Methods

Patients with stage III to IV laryngeal squamous cell carcinoma treated under a bioselection paradigm were included. Immunohistochemistry for CD8 + T‐cells and CAIX was performed. Nonparametric tests and Kaplan‐Meier survival analyses were used to compare tumor CAIX status by clinicopathologic variables and CD8 + T‐cell infiltration and to evaluate the role of CAIX and combination CAIX/tumor infiltrating lymphocytes (TIL) category on survival.

Results

Our cohort included 92 patients (n = 68 [73.9%] supraglottic). No difference in CAIX staining was seen by tumor subsite, stage, and response to induction chemotherapy (all P > .05). Thirteen (14.1%) tumors were CAIX‐positive and showed significantly lower CD8 + T‐cell infiltration than CAIX‐negative tumors (18 [0‐62] vs 32 [0‐399], P = .028). Combination CAIX/TIL category was significantly associated with the likelihood of response (CAIX−/TIL[high] were less likely to respond) and in the group of responders, was predictive of a higher degree of tumor shrinkage (>80%).

Conclusion

CAIX staining correlates with reduced CD8 + T‐cell infiltration in patients with advanced laryngeal squamous cell carcinoma undergoing bioselection. The combination CAIX/TIL category is associated with the likelihood and degree of response to induction. The utility of CAIX status and other combination immune and hypoxia signatures as a biomarker of induction response and survival merits prospective evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingTumor HypoxiaCarcinoma, Squamous CellHumansMaleRetrospective StudiesFemaleMiddle AgedAgedCarbonic Anhydrase IXNeoplasm StagingImmunohistochemistryAdultAged, 80 and overBiomarkers, TumorAntigens, Neoplasm

Stichwörter der Autor:innen

TILcarbonic anhydrasehypoxialarynxsquamous cell carcinoma

Substanzen

Carbonic Anhydrase IXCA9 protein, humanBiomarkers, TumorAntigens, Neoplasm

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  • Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Internal Medicine, Division of Medical Oncology, University of Michigan, Ann Arbor, Michigan, USA.

Förderung

  • NIDCD NIH HHS

Zitieren

APA

Smith, J. D., Gensterblum-Miller, E., Forner, D. W. A., Yalamanchi, P., Buchakjian, M. R., Chinn, S. B., Shuman, A. G., Casper, K. A., Malloy, K. M., Stucken, C. L., Mclean, S. A., Mierzwa, M. L., Shah, J., Swiecicki, P. L., Worden, F. P., Prince, M. E. P., Spector, M. E., Brenner, J. C., & Heft Neal, M. E. (2025). Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1291

Vancouver

Smith JD, Gensterblum-Miller E, Forner DWA, Yalamanchi P, Buchakjian MR, Chinn SB, et al. Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1291

BibTeX
@article{Smith2025,
  author = {Smith, Joshua D and Gensterblum-Miller, Elizabeth and Forner, David W A and Yalamanchi, Pratyusha and Buchakjian, Marisa R and Chinn, Steven B and Shuman, Andrew G and Casper, Keith A and Malloy, Kelly M and Stucken, Chaz L and Mclean, Scott A and Mierzwa, Michelle L and Shah, Jennifer and Swiecicki, Paul L and Worden, Francis P and Prince, Mark E P and Spector, Matthew E and Brenner, J Chad and Heft Neal, Molly E},
  title = {Tumor Hypoxia and CD8 + T‐Cell Infiltration in Patients With Advanced Laryngeal Cancer},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1291}
}
Kostenlos starten →